Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

2.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
3.

Surgical treatment of ventricular septal defect following myocardial infarction: a case report.

Ereminienė E, Jurgaitienė R, Benetis R, Bakšytė G, Stanaitienė G.

Medicina (Kaunas). 2013;49(4):200-5.

4.

The comparison of 2-dimensional with 3-dimensional hepatic visualization in the clinical hepatic anatomy education.

Jurgaitis J, Paskonis M, Pivoriūnas J, Martinaityte I, Juska A, Jurgaitiene R, Samuilis A, Volf I, Schöbinger M, Schemmer P, Kraus TW, Strupas K.

Medicina (Kaunas). 2008;44(6):428-38.

5.

Morphometric study of age-related changes in the human intracardiac ganglia.

Jurgaitiene R, Pauziene N, Azelis V, Zurauskas E.

Medicina (Kaunas). 2004;40(6):574-81.

Supplemental Content

Loading ...
Support Center